or on the link below. Immune checkpoint inhibitors (ICIs) have significantly transformed the treatment paradigm for metastatic renal cell carcinoma (RCC), offering prolonged overall survival and ...

Anti-C1q antibodies are a promising marker for the diagnosis and management of lupus nephritis. Immunological tests can differentiate proliferative from non-proliferative lupus nephritis, but anti-C1q ...

Find out more about the potential use of the neutrophil-to-lymphocyte ratio to identify those at risk of diabetic nephropathy.

Lupus, a chronic autoimmune disease, can wreak havoc on an affected individual's body through inflammation, pain and even damage of the skin, joints and organs. To try to better understand how the ...

Dr. Wenxin (Vincent) Xu discussed the benefit of using biomarkers to more precisely guide treatment for patients with renal cell carcinoma. At the 2025 Kidney Cancer Research Summit, Dr. Wenxin ...

STOCKHOLM — People with difficult to diagnose kidney diseases linked to nephrotic syndrome show uniquely high levels of antinephrin autoantibodies, suggesting a novel biomarker and breakthrough ...

Biomarkers that could help predict and manage chronic kidney disease (CKD) have been identified in a new study led by the University of Surrey. The research, funded by Kidney Research UK, and as part ...

Biomarkers associated with cognitive impairment differ between men and women with chronic kidney disease, according to data ...

An expert said that he is optimistic about the future use of biomarkers in the kidney cancer space. Not all patients with kidney cancer need to undergo extensive biomarker testing with the current ...